ICEF15, autologous myoblasts for fecal incontinence
ICEF15 is comprised of autologous myoblasts collected from the upper arm for the treatment of fecal incontinence. The patient’s ex vivo-expanded muscle cells are re-injected into the patient’s external anal sphincter muscle, using Innovacell’s proprietary injection device, leading to regeneration of the muscle´s full functionality.
Treatment induced a rapid and sustained reduction in the symptoms of fecal incontinence, as well as an improvement in the quality of life.
Read More
Clinical trial 2010-021463-32 phase 2.
Read More
Product Information for
ICEF15, autologous myoblasts for fecal incontinence
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access